Galderma announces positive Phase 2B Results for Investigational Compound targeting Redness of Rosacea Press release
Galderma announces positive US pivotal interim 6-month results for EMERVEL Classic Lidocaine compared to JUVEDERM Ultra Press release
AstraZeneca and Galderma enter into R&D collaboration to develop new treatments for dermatological diseases Press release
Galderma Received FDA Approval of Differin® (adapalene) Lotion, 0.1%, the First Retinoid Available in Lotion Formulation Press release
